Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Birabresib |
Trade Name | |
Synonyms | Y-803|MK-8628|OTX015|OTX-015 |
Drug Descriptions |
Birabresib (OTX015) is an inhibitor of the BET bromodomain proteins BRD3, BRD4, and BRD5, which inhibits interaction with acetylated histone H4, potentially resulting in decreased tumor cell proliferation (Mol Cancer Ther Nov 2013 12:C244, PMID: 29733771, PMID: 31204545). |
DrugClasses | BET Inhibitor (Pan) 32 |
CAS Registry Number | 202590-98-5 |
NCIT ID | C103298 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Birabresib | Birabresib | 3 | 3 |
Birabresib + Bortezomib | Birabresib Bortezomib | 0 | 0 |
Birabresib + Carfilzomib | Birabresib Carfilzomib | 0 | 0 |
Birabresib + Crizotinib | Birabresib Crizotinib | 0 | 0 |
Birabresib + GSK2801 | Birabresib GSK2801 | 0 | 0 |
Birabresib + Osimertinib | Birabresib Osimertinib | 0 | 0 |
Birabresib + Rucaparib | Birabresib Rucaparib | 0 | 0 |
Birabresib + Ziftomenib | Birabresib Ziftomenib | 0 | 0 |